Australian Agricultural Projects Limited (AAP) ORDINARY FULLY PAID |
Consumer Staple |
$17 |
Quarterly Update and Appendix 4C - June 2025
|
29 Jul 2025 11:53AM |
$0.049 |
$0.047 |
fallen by
4.08%
|
|
AAP - Price-sensitive ASX Announcement
Full Release
Key Points
- AAP completed the annual olive harvest with improved yields and oil content compared to previous years.
- Rainfall and weather conditions positively influenced production outcomes during the quarter.
- Cash flow report details receipts from customers and payments for orchard and corporate expenses.
- The company maintained a focus on operational improvements and cost control measures.
- Statutory ASX disclosures and Appendix 4C are included in the report.
- Outlook discusses plans for continued productivity enhancements and financial stability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Munro Concentrated Global Growth Fund (Managed Fund) (MCGG) |
Financials |
$64 |
Monthly Portfolio Holdings - June 2025
|
29 Jul 2025 11:51AM |
$14.920 |
$15.060 |
risen by
0.94%
|
|
Munro Climate Change Leaders Fund (Managed Fund) (MCCL) |
Financials |
$127 |
Monthly Portfolio Holdings - June 2025
|
29 Jul 2025 11:49AM |
$17.200 |
$16.320 |
fallen by
5.12%
|
|
Carnavale Resources Limited (CAV) ORDINARY FULLY PAID |
Materials |
$16 |
Becoming a substantial holder - P Reese
|
29 Jul 2025 11:48AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
Munro Global Growth Fund (MAET) |
Financials |
$310 |
Monthly Portfolio Holdings - June 2025
|
29 Jul 2025 11:47AM |
$6.170 |
$6.220 |
risen by
0.81%
|
|
Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$41 |
Amended Quarterly Activities/Appendix 4C Cash Flow
|
29 Jul 2025 11:45AM |
$0.155 |
$0.143 |
fallen by
8.06%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Nova Eye Medical Limited reported quarterly activities and cash flows for the period ending 30 September 2023.
- Sales of iTrack Advance increased in the US and European markets.
- Molteno3 glaucoma drainage device sales continued to grow.
- Investments in research and development remained a focus to support commercial strategy.
- Cash at the end of the quarter was reported, with sufficient reserves for ongoing operations.
- The company highlighted ongoing regulatory and commercialization activities.
- Strategic priorities include expanding market reach and new product development.
- No significant changes to related party arrangements were reported.
- Amendments in the report relate to corrections in specific financial figures and clarifications.
- Market trends indicate sustained demand for ophthalmic medical devices, particularly for glaucoma treatment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$53 |
Notification of cessation of securities - BOL
|
29 Jul 2025 11:44AM |
$1.355 |
$1.290 |
fallen by
4.80%
|
|
EnviroSuite Limited (EVS) ORDINARY FULLY PAID |
Information Technology |
$131 |
Notice regarding Second Court Hearing
|
29 Jul 2025 11:43AM |
$0.087 |
$0.090 |
risen by
2.87%
|
|
AML3D Limited (AL3) ORDINARY FULLY PAID |
Industrials |
$140 |
Exercise of Options and Cleansing Notice
|
29 Jul 2025 11:42AM |
$0.285 |
$0.255 |
fallen by
10.53%
|
|
AML3D Limited (AL3) ORDINARY FULLY PAID |
Industrials |
$140 |
Application for quotation of securities - AL3
|
29 Jul 2025 11:41AM |
$0.285 |
$0.255 |
fallen by
10.53%
|
|
Central Petroleum Limited (CTP) ORDINARY FULLY PAID |
Energy |
$45 |
Becoming a substantial holder
|
29 Jul 2025 11:41AM |
$0.055 |
$0.060 |
risen by
9.09%
|
|
Spenda Limited (SPX) ORDINARY FULLY PAID |
Information Technology |
$23 |
Investor Webinar
|
29 Jul 2025 11:37AM |
$0.007 |
$0.005 |
fallen by
28.57%
|
|
Mount Burgess Mining NL (MTB) ORDINARY FULLY PAID |
Materials |
$4 |
June 2025 Quarterly Activities and Cash Flow Reports
|
29 Jul 2025 11:37AM |
$0.005 |
$0.009 |
risen by
80%
|
|
MTB - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly update focuses on the Kihabe-Nxuu Zinc-Lead-Silver-Germanium-Vanadium project in Botswana.
- Significant emphasis on resource estimation and metallurgical test work.
- Exploration activities and laboratory analysis reported for both the Kihabe and Nxuu deposits.
- Administrative and corporate costs, including cash flow management, are detailed.
- Ongoing funding requirements and strategic planning for project advancement are discussed.
- Progress on project feasibility studies and development programs highlighted.
- Challenges identified include further exploration funding and technical evaluation.
- Company continues to engage with stakeholders and pursue partnerships for project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,795 |
Securities Trading Policy
|
29 Jul 2025 11:34AM |
$19.030 |
$26.330 |
risen by
38.36%
|
|
Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$10 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 11:34AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 1A trial for CHM 1101 (CLTX CAR T) in glioblastoma successfully completed, meeting safety and tolerance endpoints.
- Phase 1B trial for CHM 1101 initiated, focusing on dose expansion and additional patient enrolment.
- Advancement in preclinical development for other cell therapy product candidates, including CHM 2101 and ADTC clinical programs.
- Continued manufacturing readiness, with process improvements made for clinical supply needs.
- Regulatory milestones achieved, including approvals to commence additional studies and ongoing engagement with international regulatory agencies.
- Publication of key scientific findings in peer-reviewed journals and presentations at major industry conferences.
- Strengthened collaborations with academic and clinical partners to accelerate research and trial recruitment.
- Cash flow report details operating cash outflows of approximately $3.2 million for the quarter, with a reported cash balance sufficient for ongoing operations.
- No significant revenue generated; primary expenditures related to R&D, staff costs, and administration.
- Commitment to operational efficiency and financial discipline while advancing clinical and preclinical programs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
EQT Holdings Limited (EQT) ORDINARY FULLY PAID |
Financials |
$726 |
Details for EQT's Full Year Results release and webinar
|
29 Jul 2025 11:34AM |
$32.450 |
$27.110 |
fallen by
16.46%
|
|
Aurora Energy Metals Limited (1AE) ORDINARY FULLY PAID |
Materials |
$13 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jul 2025 11:30AM |
$0.047 |
$0.071 |
risen by
51.06%
|
|
1AE - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurora Energy Metals Project (AEMP) in Oregon is the company's primary focus.
- Ongoing environmental baseline studies and permitting activities progressed during the quarter.
- Initial metallurgical testwork was conducted to support the Pre-Feasibility Study (PFS).
- Community engagement activities and stakeholder communications continued.
- Exploration and development expenditure was detailed in the Appendix 5B Cash Flow Report.
- The company maintained a stable cash position, supporting ongoing project development.
- Aurora Energy Metals Limited is targeting uranium and lithium resources.
- Key work streams for the next quarter include further PFS advancement and ongoing studies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
DevEx Resources Limited (DEV) ORDINARY FULLY PAID |
Materials |
$39 |
Notification regarding unquoted securities - DEV
|
29 Jul 2025 11:27AM |
$0.082 |
$0.089 |
risen by
8.54%
|
|
Hydrocarbon Dynamics Limited (HCD) ORDINARY FULLY PAID |
Energy |
$2 |
Revised Appendix 5B
|
29 Jul 2025 11:25AM |
$0.003 |
$0.002 |
fallen by
33.33%
|
|
Voltaic Strategic Resources Ltd (VSR) ORDINARY FULLY PAID |
Materials |
$14 |
Becoming a substantial holder
|
29 Jul 2025 11:23AM |
$0.017 |
$0.024 |
risen by
41.18%
|
|
N1 Holdings Limited (N1H) ORDINARY FULLY PAID |
Financials |
$9 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 11:22AM |
$0.110 |
$0.105 |
fallen by
4.55%
|
|
N1H - Price-sensitive ASX Announcement
Full Release
Key Points
- N1 Holdings Limited lodged its Quarterly Activities/Appendix 4C Cash Flow Report for the quarter ending 31 March 2024.
- The company continues to focus on mortgage management, commercial lending, and advisory services.
- Commercial lending division experienced further growth during the quarter.
- New funding arrangements were put in place to support lending activities.
- The mortgage management portfolio continued performing steadily.
- Net cash outflows from operating activities were primarily due to staff, administration, and operating expenses.
- Receipts from customers provided partial offset to operating cash outflows.
- No significant business acquisitions or disposals occurred during the quarter.
- The company reported sufficient cash reserves and does not foresee the need for additional funding in the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Epsilon Healthcare Limited (EPN) ORDINARY FULLY PAID |
Health Care |
$9 |
Strategic $6.7m Sale and Leaseback of Southport Property
|
29 Jul 2025 11:21AM |
$0.024 |
$0.024 |
fallen by
0%
|
|
Raptis Group Limited (RPG) ORDINARY FULLY PAID |
Real Estate |
$39 |
Initial Director's Interest Notice
|
29 Jul 2025 11:20AM |
$0.235 |
$0.110 |
fallen by
53.19%
|
|
Garda Diversified Property Fund (GDF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$270 |
Cairns Corporate Tower Sale
|
29 Jul 2025 11:19AM |
$1.230 |
$1.245 |
risen by
1.22%
|
|
Metals X Limited (MLX) ORDINARY FULLY PAID |
Materials |
$572 |
2025 Renison Mineral Resource Update
|
29 Jul 2025 11:15AM |
$0.615 |
$0.645 |
risen by
4.88%
|
|
MLX - Price-sensitive ASX Announcement
Full Release
Key Points
- 2025 Renison Mineral Resource Update released by Metals X Limited.
- Increase in total estimated mineral resources at Renison Tin Operations.
- Exploration success led to an upgrade in both resource size and confidence.
- Comprehensive methodology for geological modeling and resource estimation described.
- Comparison with the previous resource update provided.
- Updated mineral resource figures, including tonnage and contained tin metal.
- Breakdown of resources by classification (Measured, Indicated, Inferred).
- Details on data collection, sampling, quality assurance, and quality control included.
- Geological interpretation and 3D modeling processes outlined.
- Discussion of key mining areas and their resource status.
- Implications for future mining, exploration, and operational planning.
- Compliance with JORC 2012 reporting standards emphasized.
- Summary of exploration activities and drilling results since the last update.
- No significant changes in economic assumptions or cut-off grades since previous update.
- The update supports ongoing mining activities and potential for further resource growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.